Sethi Lab News Today

Research from Dana-Farber Cancer Institute looks at what happens before the emergence of mutations that interrupt cellular differentiation in colorectal cancer and finds not only evidence of fetal reprogramming that can initiate cancer, but also a protein, Sox9, that fuels that reprogramming.

Grant Awarded to Explore Hopeful New Treatment Strategies for Gastric and Esophageal Cancers News provided by Share this article Share this article NEW YORK, March 2, 2021 /PRNewswire/ -- The DeGregorio Family Foundation, with funding support from the Price Family Foundation and the Esophageal Cancer Awareness Association, has awarded $200,000 to Dr. Nilay Sethi, Principal Investigator at Dana-Farber Cancer Institute. Dr. Nilay Sethi, Dana-Farber Cancer Institute Dr. Sethi is a physician-scient...